Understanding vaccine perceptions and willingness to receive COVID-19 vaccination: opportunities to strengthen public health responses and COVID-19 services for …

AE Jordan, R Izar, R Nicolas, N Beharie, A Harocopos - Vaccines, 2022 - mdpi.com
Background: People who use drugs (PWUD) are at high risk for COVID-19 infection,
morbidity, and mortality. COVID-19 vaccines are safe and effective at reducing serious …

Mortality among patients with COVID-19 and different interstitial lung disease subtypes: a multicenter cohort study

J Zhao, B Metra, G George, J Roman… - Annals of the …, 2022 - atsjournals.org
Methods To address this, we performed a large, retrospective cohort study to evaluate
outcomes from SARS-CoV-2 infection among patients with different ILD subtypes. Analyses …

Cannabis, Tobacco Use, and COVID-19 Outcomes

NB Griffith, TB Baker, BT Heiden, N Smock… - JAMA Network …, 2024 - jamanetwork.com
Importance It is unclear whether cannabis use is associated with adverse health outcomes
in patients with COVID-19 when accounting for known risk factors, including tobacco use …

Chronic pancreatitis and risk of atherosclerotic cardiovascular disease: a US cohort propensity-matched study

A Desai, S Chandan, D Ramai, V Kaul, GS Kochhar - Pancreas, 2023 - journals.lww.com
Objectives Worldwide prevalence of chronic pancreatitis (CP) has risen in recent years, with
data suggesting an increased risk of atherosclerotic cardiovascular disease (ASCVD) in …

People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard …

M Gainullin, L Federico, J Røkke Osen… - Frontiers in …, 2024 - frontiersin.org
People who use drugs (PWUD) are at a high risk of contracting and developing severe
coronavirus disease 2019 (COVID-19) and other infectious diseases due to their lifestyle …

[HTML][HTML] Longitudinal trajectories of psychosocial functioning in patients with pre-existing mental disorders after one year of COVID-19 pandemic

M Luciano, C Carmassi, G Sampogna… - Journal of Psychiatric …, 2024 - Elsevier
Aims of the present study were to prospectively assess psychosocial functioning trajectories
during the COVID pandemic and the possible impact of sociodemographic variables, as well …

[HTML][HTML] Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide …

M Glancy, A Yeung, A McAuley, N Palmateer… - Clinical Microbiology …, 2024 - Elsevier
Objectives Among people receiving opioid-agonist treatment (OAT), the risk of COVID-19
infection and disease may be higher owing to underlying health problems and vulnerable …

Longitudinal trajectories of anxiety and depression in subjects with different mental disorders after one year in the COVID-19 pandemic

C Carmassi, S Tosato, V Pedrinelli, CA Bertelloni… - Psychiatry …, 2024 - Elsevier
The aim of this study was to prospectively assess the development and trajectories of
anxiety and depressive symptoms among subjects with different mental disorders, during the …

Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder

SE Clingan, SJ Cousins, C Lin, TE Nguyen… - Annals of …, 2023 - Taylor & Francis
Abstract Introduction The Coronavirus Disease 2019 (COVID-19) pandemic has had
devastating consequences for persons with opioid use disorder (OUD). Yet, little is known …

Mental health conditions and COVID-19 vaccine outcomes: a scoping review

R Jia, C Coupland, Y Vinogradova, N Qureshi… - Journal of …, 2024 - Elsevier
Objective Research shows that people with a history of mental health conditions were at
increased risk of COVID-19 infection, hospitalisation, and mortality. However, the …